CN102309708B - Drug for treating tumor - Google Patents
Drug for treating tumor Download PDFInfo
- Publication number
- CN102309708B CN102309708B CN201110266963A CN201110266963A CN102309708B CN 102309708 B CN102309708 B CN 102309708B CN 201110266963 A CN201110266963 A CN 201110266963A CN 201110266963 A CN201110266963 A CN 201110266963A CN 102309708 B CN102309708 B CN 102309708B
- Authority
- CN
- China
- Prior art keywords
- drug
- treating tumor
- tumor
- chinese
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 229940079593 drug Drugs 0.000 title claims abstract description 10
- 206010028980 Neoplasm Diseases 0.000 title abstract description 23
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 241001082427 Euphorbia lunulata Species 0.000 abstract 1
- 240000003915 Lophatherum gracile Species 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000003582 Platycodon grandiflorus Species 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 5
- 208000020816 lung neoplasm Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to a drug for treating tumor. The drug for treating tumor is prepared from lophatherum gracile, Chinese paris rhizome, bighead atractylodes rhizome, rhizoma atractylodis, euphorbia lunulata, rheum officinale, balloonflower root, tuber of dwarf lilyturf, Chinese angelica, rhizoma sparganii, Chinese magnoliavine and barbat skullcap. The drug for treating tumor is prepared from the pour traditional Chinese medicines and thus having natural drug characteristics of low toxicity and good curative effects. The drug for treating tumor has clear curative effects and can treat tumor effectively.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of medicament of treating tumor.
Background technology
Tumor be body under various carcinogenic factor effects, some cells of local organization lose the normal regulation to its growth on gene level, cause its clonal abnormality hypertrophy and the neoplasm that forms.It is generally acknowledged that tumor cell is a monoclonicity, promptly all oncocytes in tumor all are offsprings of the cell of a sudden change.Generally tumor is divided into optimum and pernicious two big types.All malignant tumor are generically and collectively referred to as cancer.
Many clinically at present employing chemicalses are treated, but often the injury for the patient is bigger for chemotherapeutics.
Summary of the invention
The purpose of this invention is to provide a kind of medicament of treating tumor.
In order to realize the object of the invention, the present invention provides a kind of medicament of treating tumor, and it is processed by following bulk drugs by weight:
Preferably, it is processed by following bulk drugs by weight:
Preferably, medicament of the present invention is tablet, dispersible tablet, decoction or capsule.
Medicament of the present invention is prepared with pure Chinese medicine, keeps little, the eutherapeutic characteristic of natural drug toxicity, and curative effect is clear and definite, can treat tumor effectively.
The specific embodiment
Below description through the specific embodiment the present invention is described further; But this is not to be limitation of the present invention; Those skilled in the art are according to basic thought of the present invention; Can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get Herba Lophatheri 100 gram, Rhizoma Paridis 100 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Rhizoma Atractylodis 30 grams, Herba euphorbiae lunulatae 100 grams, Radix Et Rhizoma Rhei 50 grams, Radix Platycodonis 50 grams, Radix Ophiopogonis 100 gram, Radix Angelicae Sinensis 50 grams, triangular 50 grams, Fructus Schisandrae Chinensis 100 grams, Herba Scutellariae Barbatae 100 grams; Place 800 ml waters; 90 ℃ of following reflux 3 hours; Filter, obtain filtering residue and filtrating.Said filtrating is concentrated into 300 milliliters, promptly gets.
Experimental example
Be the therapeutic effect that example is investigated medicament of the present invention with pulmonary carcinoma now, this is intended to is schematic and nonrestrictive.
Physical data
40 routine patients with lung cancer all are diagnosed as medium and advanced lung cancer through CT and cytology or pathology.Wherein, male 20 examples, women 20 examples, minimum 44 years old of age, maximum 76 years old, average 60 years old; Classification: scale cancer 19 examples, adenocarcinoma 12 examples, mixed carcinoma 9 examples.Quality of life Ka Shi scoring all＞30 minutes.
Take the decoction of preparation among the embodiment 1, three times on the one, each 50 milliliters.60 days is 1 course of treatment.Period in a medicine does not all adopt measures such as any chemotherapy, radiotherapy.
The therapeutic evaluation standard
According to short term effect observation, 2 indexs of appraisal of life quality, observe therapeutic effect.
1. short term effect observe the curative effect standard: according to the objective efficacy assessment standard of WHO treatment of cancer (Chinese Anti-Cancer Association. newly organized common cancer diagnosis and treatment standard primary bronchogenic carcinoma of lung fascicle [S]. Beijing: the .1999:14-26.541. of combined publication society of China Concord Medical Science University of Beijing Medical University); Different by treatment tumor size variation, curative effect is divided into 4 grades.1. alleviate fully: the tumor focus complete obiteration is also kept more than 4 weeks at least; 2. part is alleviated: the product of the maximum gauge of tumor focus and maximum perpendicular transverse diameter dwindles >=and 50%, and keep more than 4 weeks, there is not new focus appearance; 3. stable: two footpath products of swollen lame focus dwindle＜and 50%, increase＜25%, keep more than 4 weeks, do not have new focus and occur; 4. worsen progress: tumor increases >=25% or new focus occurs.
2. appraisal of life quality: by the Ka Shi standards of grading (look into people person of outstanding talent. modern pulmonary cancer diagnosis and treatment (M) .2 version. Beijing: People's Medical Officer Press .1999:416), rise and 10 be divided into effectively in the treatment back, descends to 10 being divided into invalidly, goes up and down between 10 minutes for stable.
Therapeutic outcome
1. short term effect is observed: alleviate 10 examples fully, part is alleviated 6 examples, stablizes 24 examples, worsens progress 0 example.
2. quality of life treatment back Ka Shi scoring, effective 16 examples of therapeutic effect, therapeutic effect is stablized 24 examples, therapeutic effect 0 example that descends.
Claims (3)
1. medicament of treating pulmonary carcinoma is characterized in that it is processed by following bulk drugs by weight:
2. the medicament of treatment pulmonary carcinoma according to claim 1 is characterized in that, it is processed by following bulk drugs by weight:
3. the medicament of treatment pulmonary carcinoma according to claim 1 and 2 is characterized in that, said medicament is tablet, decoction or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110266963A CN102309708B (en) | 2011-09-09 | 2011-09-09 | Drug for treating tumor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110266963A CN102309708B (en) | 2011-09-09 | 2011-09-09 | Drug for treating tumor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102309708A CN102309708A (en) | 2012-01-11 |
| CN102309708B true CN102309708B (en) | 2012-10-17 |
Family
ID=45423516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110266963A Expired - Fee Related CN102309708B (en) | 2011-09-09 | 2011-09-09 | Drug for treating tumor |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102309708B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526543B (en) * | 2012-03-23 | 2013-05-29 | 崔巍 | Decoction for treating lung cancer |
| CN103393743B (en) * | 2013-07-10 | 2015-12-23 | 聂纪强 | A kind of Chinese medicine composition for the treatment of tumor |
| CN106389546A (en) * | 2016-10-18 | 2017-02-15 | 漯河医学高等专科学校 | Traditional Chinese medicine for postoperative treatment of colorectal cancer and preparation method of traditional Chinese medicine |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101829283A (en) * | 2009-03-09 | 2010-09-15 | 朱敏 | Traditional Chinese medicine for treating lung cancer, gastric cancer, bone marrow cancer and metrocarcinoma and preparation method thereof |
-
2011
- 2011-09-09 CN CN201110266963A patent/CN102309708B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101829283A (en) * | 2009-03-09 | 2010-09-15 | 朱敏 | Traditional Chinese medicine for treating lung cancer, gastric cancer, bone marrow cancer and metrocarcinoma and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 中药对肺癌细胞增殖与凋亡影响的研究进展;顾后等;《云南中医中药杂志》;20071231;第28卷(第5期);42-44 * |
| 顾后等.中药对肺癌细胞增殖与凋亡影响的研究进展.《云南中医中药杂志》.2007,第28卷(第5期),42-44. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102309708A (en) | 2012-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104352608B (en) | A kind of benefiting QI for activating blood circulation, hard masses softening and resolving, the Chinese medicine and preparation method thereof of removing toxic substances pain relieving | |
| CN102008650B (en) | Compound traditional Chinese medicine preparation for treating tumors and preparation method thereof | |
| CN102284049A (en) | Traditional Chinese medicine compound preparation for resisting ulcer and relieving chemoradiotherapeutic toxic and side effects, and preparation method and application thereof | |
| CN102309708B (en) | Drug for treating tumor | |
| CN102861193B (en) | Traditional Chinese medicine composition for treating gastric cancer | |
| CN102688317B (en) | Traditional Chinese medicine for treating liver cancer | |
| CN101804189B (en) | Drug for treating primary dysmenorrhea | |
| CN108186794B (en) | Traditional Chinese medicine composition for treating lung cancer and preparation method and application thereof | |
| CN103550718B (en) | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma | |
| CN102302719B (en) | Medicament for treating tumor | |
| CN102028924A (en) | Medicinal composition for late gastric cancer | |
| CN104189782A (en) | Anti-tumor medicament composition | |
| CN107137416A (en) | A kind of pharmaceutical composition for preventing and treating non-small cell lung cancer | |
| CN104524163B (en) | A kind of Chinese medicine composition and preparation method for the treatment of chronic bronchitis and merging pulmonary carcinoma | |
| CN102836354B (en) | Medicament for treating depression | |
| CN101979076B (en) | Compound combination medicament for treating cerebral metastatic tumor and preparation method and application thereof | |
| CN102038821A (en) | Method for preparing medicinal composition for treating dysmenorrhea | |
| CN104888149A (en) | Drug for treating cervical cancer and preparation method for drug | |
| CN106138697B (en) | Chinese medicinal composition for preventing complications and relieving side effects of radiotherapy and chemotherapy of tumor patients | |
| CN102526543B (en) | Decoction for treating lung cancer | |
| CN104127532B (en) | The application of a kind of NAOXINTONG JIAONANG in preparation treatment oncosis medicine | |
| CN103599167B (en) | A kind of medicament for the treatment of pulmonary carcinoma | |
| CN101693096A (en) | Medicament for treating liver cancer and preparation method thereof | |
| CN101703718A (en) | Anti-tumor compound Chinese medicinal preparation | |
| CN102416147B (en) | Medicinal composition for treating mania of patients abstained from drugs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: TIANJIANG PHARMACEUTICAL INDUSTRY CO., LTD., JIANG Free format text: FORMER OWNER: CUI WEI Effective date: 20130628 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 273500 JINING, SHANDONG PROVINCE TO: 214400 WUXI, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130628 Address after: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8 Patentee after: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin Address before: 273500 Shandong city of Jining province Guhuai Road No. 79 oncology Affiliated Hospital of Jining Medical College Patentee before: Cui Wei |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170420 Address after: Fan Dian Cun 062650 Cangzhou city of Hebei Province, Qingxian County Town, 1 groups of 38, Qingzhou Patentee after: Wu Jingjing Address before: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8 Patentee before: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin |
|
| CP02 | Change in the address of a patent holder | ||
| CP02 | Change in the address of a patent holder |
Address after: Liao LAN Zhen He Jia Dian Lu rock Pingdu City of Qingdao province No. 1 Shandong 266700 Patentee after: Wu Jingjing Address before: Fan Dian Cun 062650 Cangzhou city of Hebei Province, Qingxian County Town, 1 groups of 38, Qingzhou Patentee before: Wu Jingjing |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121017 Termination date: 20170909 |